跳至主要内容
临床试验/NCT00433797
NCT00433797已完成1 期

Prostate Phytochemical & PUFA Intervention - a Phase I/II Study

University of Oslo2 个研究点 分布在 1 个国家目标入组 86 人开始时间: 2007年6月最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
86
试验地点
2
主要终点
serum prostate specific antigen

研究概览

简要总结

We will study the effect of dietary intervention in patients with prostate cancer. Outcomes include serum PSA kinetics, as well as biomarkers of inflammation, antioxidant status, oxidative stress and oxidative damage in blood cells, plasma, urine and prostate tissues

详细描述

A total of 102 patients with localized prostate cancer will be included in the study. A the time of inclusion, the participants will be randomized to three groups.

The intervention groups includes; control group, tomato group and multi-diet group. The intervention period is three week and will be completed before prostatectomy or radiation therapy.

Biomarkers og inflammation includes: acute phase proteins, cytokines, chemokines and other inflammatory mediators. Biomarker of antioxidant status includes vitamin C, vitamin E, glutathione, carotenoids, total antioxidant capacity and total phenolics. Oxidative stress markers includes; malondialdehyde, isoprostanes, 8-hydroxy-deoxyguanosine, oxidized vitamin C, total lipidperoxides (d-ROM) and protein carbonyls.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

性别
Male
接受健康志愿者

入选标准

  • Adenoarcinoma (as confirmed by histology)
  • pN0/NXM0 (TNM/UICC 2002) and at least one negative prognosis factor for HDR-BT or low risk profile with the use of radical prostatectomy.
  • Serum PSA< 20 ng/mL, and Gleason score =>6 or T1c- T3a, prostate volume < 60mL
  • Performance status 0-1
  • Normal WBC and thromocytes, Hb >11g/dl

排除标准

  • No previous endocrine treatment
  • Life expectancy > 5 år
  • No possible co-morbidity (CVD, COPD, diabetes type I, vasculatory syndromes or inflammatory diseases that may affect quality of life and radiation therapy)
  • Urinary retention, incontinens or IPPS score <12

结局指标

主要结局

serum prostate specific antigen

时间窗: Baseline, after intervention, follow-up

次要结局

  • oxidative damage biomarkers in blood, tissue and urine(Baseline, after intervention, follow-up)
  • oxidative stress biomarkers in blood, tissue and urine(Baseline, after intervention, follow-up)
  • Apoptose markers in prostate tissue(Baseline, after intervention, follow-up)
  • antioxidant status biomarkers in blood, tissue and urine(Baseline, after intervention, follow-up)
  • inflammation biomarkers in blood, tissue and urine(Baseline, after intervention, follow-up)
  • DNA microarrays in blood cells and prostate tissue(Baseline, after intervention, follow-up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Rune Blomhoff

Professor

University of Oslo

研究点 (2)

Loading locations...

相似试验